About 6 results found for searched term "79-39-0" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21577 | Sirpiglenastat | Others |
| DRP-104 | ||
| Sirpiglenastat (DRP-104) is a broad acting glutamine (glutamine) antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing an effective antitumor immune response. | ||
| M42825 | Methacrylamide | Others |
| Methacrylamide can be used as an excipient. | ||
| M1776 | Rivaroxaban | Factor Xa |
| Xarelto, BAY 59-7939 | ||
| Rivaroxaban (Xarelto, BAY 59-7939) is oral direct factor Xa inhibitor with an IC50 value of 2.1nM. | ||
| M10049 | GSK2795039 | NADPH Oxidase |
| GSK-2795039 | ||
| GSK2795039 is the first small molecule NADPH oxidase 2 (NOX2) inhibitor, with a mean pIC50 of 6 in different cell-free assays. | ||
| M21550 | Recombinant Mouse/Rat TGF-beta 1 (HEK293) | Cytokines and Growth Factors |
| TGFB; TGF-b1; TGFB1; CEDLAP;latency-associated peptide | ||
| Recombinant mouse/rat transforming growth factor β1 is produced by the mammalian expression system and the target gene encoding Ala279-Ser390 is expressed. Measured by its ability to inhibit IL-4-dependent proliferation of TF‑1 human erythroleukemic cells.The ED50 for this effect is 5-25 pg/ml. | ||
| M39138 | 5-R-Rivaroxaban | Factor Xa |
| 5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban. Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
